ASNS and breast cancer: In breast cancer cells, ASNS is a target of IGF1/IGF2-dependent anabolic signaling (59), and, consistently, ASNS silencing depressed cell proliferation in two distinct cell lines, one of which derives from a triple negative tumor (60).